Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options.

about

Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway

P2860

Q36286889-6FCAC5AC-995F-42D2-B77C-552E484A5780

P2860

Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options.

Item

http://www.wikidata.org/entity/Q38720593

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Epstein-Barr virus-associated ...... lties and therapeutic options.

@en

type

Item

label

Epstein-Barr virus-associated ...... lties and therapeutic options.

@en

prefLabel

Epstein-Barr virus-associated ...... lties and therapeutic options.

@en

P1476

Epstein-Barr virus-associated ...... lties and therapeutic options.

@en

P2093

Ana Battle-Lopez

http://www.w3.org/2001/XMLSchema#string

Eulogio Conde

http://www.w3.org/2001/XMLSchema#string

Javier Nuñez

http://www.w3.org/2001/XMLSchema#string

Maria-Luisa Cagigal

http://www.w3.org/2001/XMLSchema#string

Sonia Gonzalez de Villambrosia

http://www.w3.org/2001/XMLSchema#string

P2860

Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway

Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment

Epstein-Barr virus-associated lymphomas

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

Identification of virus-encoded microRNAs

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

P304

411-421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2016.1149065

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Santiago Montes-Moreno

Miguel A. Piris

P577

2016-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26838128

http://www.w3.org/2001/XMLSchema#string

Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options.

about

P2860

P2860

Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698